http://rdf.ncbi.nlm.nih.gov/pubchem/patent/JP-2011511330-A

Outgoing Links

Predicate Object
classificationCPCAdditional http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61M2021-0044
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61N2005-0647
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61F9-022
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G02C2202-16
classificationCPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G02C7-105
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G02C5-001
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G02C7-108
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G02C7-104
classificationIPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/G02B5-22
filingDate 2009-02-05-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationDate 2011-04-07-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber JP-2011511330-A
titleOfInvention Retinal melatonin suppression device with filter layer
abstract A photoluminescent material containing a plurality of nanocrystals such as a quantum dot or a Cornell point has been proposed. Each nanocrystal absorbs electromagnetic energy at a first wavelength, and the absorbed electromagnetic energy is absorbed at a desired wavelength. Alternatively, it can be emitted in the direction toward the human retina at a selected wavelength. The emission wavelength is preferably selected for each ability to suppress naturally occurring melatonin. By placing the photoluminescent material over at least a portion of the lens, it is possible to optimize exposure to the desired wavelength while reducing the overall emission dose. The photoluminescent material is either provided as a coating on the surface of the lens that is part of the spectacle-like appliance or as part of the material applied to the lens inside the lens, or an optical therapy system It can also be applied. Furthermore, when the filter material is applied to the lens, it is possible to attenuate at least a part of the selected wavelength of light emission toward the retina.
isCitedBy http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-11672944-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/AU-2014312744-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2015030246-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-9574067-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-10203524-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/JP-2014164208-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/JP-2015049338-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/JP-2015049339-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/JP-2017533449-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/JP-2022025144-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2015030245-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/JP-2014527645-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/JP-2020190749-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/AU-2014312743-B2
priorityDate 2008-02-07-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate Subject
isCitedBy http://rdf.ncbi.nlm.nih.gov/pubchem/patent/JP-2006259079-A
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID485223053
http://rdf.ncbi.nlm.nih.gov/pubchem/gene/GID396338
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID137
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419507128
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID3037
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID16015
http://rdf.ncbi.nlm.nih.gov/pubchem/gene/GID192646
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID449483575
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID896
http://rdf.ncbi.nlm.nih.gov/pubchem/gene/GID30669
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419513448
http://rdf.ncbi.nlm.nih.gov/pubchem/gene/GID244701
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID66868
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419558200
http://rdf.ncbi.nlm.nih.gov/pubchem/gene/GID4544

Total number of triples: 46.